Robbins Chapter on Neoplasia Flashcards

1
Q

What are the two most common general epigenetic changes we see in cancer and what do they do to genes?

A

DNA Methylation: Silence gene expression

Histone modification: Can enhance or dampen gene response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss what oncogenes and oncoproteins are and what they do

A

Oncogenes are created by mutations in proto-oncogenes and encode proteins called oncoproteins that have the ability to promote cell growth in the absence of normal growth-promoting signals

These oncoproteins are usually close to identical to the normal protein products but tend to have internal regulators shut off so that the external environment doesn’t shut them off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss the pathway of growth factor receptors that is absolutely key to understanding the biochemistry of cancer (just about 100% of cancers are due to effects in this pathway)

A

Basically, growth factor receptors get a signal from a growth factor that causes Inactive RAS to activate. Active RAS activates RAF, which activates MAPK leading to activation of transcription, causing upregulation of MYC (Progrowth metabolism and increased protein synthesis) and D cyclins (cell cycle progression).

Active RAS also activates PI3K which turns on AKT (helps progrowth metabolism) which turns on mTOR (helps protein synthesis).

These changes cause cell growth

GAP turns the Active RAS to Inactive and PTEN stops PI3K progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In regards to any cancer involving the epithelium, there is a stepwise mechanism involved in turning that epithelium unto a metastasis. Each of these events is associated with a genetic alteration. Discuss this stepwise progression.

A

So we have normal epithelium. With activation of the Wnt pathway due to APC, we turn this normal epithelium to an early adenoma or dysplastic crypt.

EGFR signaling via a KRAS mutation then occurs, turning this early change into an intermediate adenoma.

Intermediate gets turned to late adenoma via inactivation of TGF-B due to a Smad 2/4 mutation (this is not terribly high yield)

We get carcinoma finally because of a loss in p53, and eventually, due to other genetic alterations, this carcinoma metastasizes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is BRAF and what is it linked to

A

BRAF: Hairy Cell Leukemia, melanoma, benign nevi

Serine/threonine protein kinase of the MAPK family. Activating mutation for pro-growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss the common mutation we see with the ABL Tyrosine kinase and what it leads to

A

In CML, ABL tyrosine kinase from Chromosome 9 translocates to Chromosome 22 and fuses with BCR, getting constitutively activated. Interestingly, even though CML is associated with a ton of other gene issues and receptor issues, blocking this BCR-ABL kinase with designer drugs can be extremely effective in stopping replication of CML. We call a weakness like this an “oncogene addiction”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Discuss what MYC is and what it is linked to

A

MYC: A transcription factor: Increased expression of this causes disregulatino of cell growth (Burkitt Lymphoma and other hematologic malingnancies), gene amplification (neuroblastoma) and increased activity of upstream signaling pathways (a bunch of cancers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is CDK4?

A

CDK4: Cyclin dependent kinase. Mutation promotes cell cycle progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does RB do and how is it linked to cancer?

A

RB: When hypophosphorylated, RB exerts antiproliferative effects by binding to and inhibiting E2F transcription factors that regulate genes required for cells to pass through the G1-S phase checkpoint.

We normally hyperphosphorylate (inactivate) this to progress cell cycle when needed. Cancers cause loss of function in the RB allele to stop its antiproliferative effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What four issues can occur with the RB pathway to cause cancer

A

Loss of function mutations of RB

Gene amplification of CDK4 and Cyclin D genes

Loss of cyclin-dependent kinase inhibitors (p16 and INK4A)

Viral oncoproteins that bind and inhibit RB (E7 protein of HPV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss the importance of p53 and its link to cancer (the specific pathway)

A

p53 protein - Central monitor of stress in the cell and is activated by anoxia, mutated oncoproteins or damaged DNA. DNA damage is sensed by complexes containing kinases of the ATM/ATR family, and they phosphorylate p53, liberating it from inhibitors like MDM2. Active p53 then upregulates the expression of proteins like CDK inhibitor p21, thereby causing the arrest of the cell cycle at G1-S checkpoint, allowing for repair of the damaged DNA. No repair capable = p53 induced apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do we see with APC issues?

A

APC - Encodes a factor that negatively regulates the WNT pathway in colonic epithelium by promoting the formation of a complex that degrades B-catenin. FAP with loss of a single allele and colon carcinoma with both alleles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Importance of E-cadherin?

A

E-cadherin - Loss of function = gastric carcinoma due to loss of contact inhibition (cells touching each other need to stop replicating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Importance of CDKN2A

A

CDKN2A - Encodes two tumor suppressor proteins: p16/INK4A that augments RB function and ARF which stabilizes p53. Germline loss of function = familial melanoma. Both leads to leukemias, melanomas, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is TGF-B linked to cancer?

A

TGF-B: Potent inhibitor of cellular proliferation. Mutations lead to immune evasiveness in cancer and proliferation of various cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PTEN and how it is linked to cancer

A

PTEN: lipid phosphatase that turns off PI3K/AKT signaling. Germline loss of function = Cowden syndrome = high risk of breast and endometrial cancer

17
Q

NF1 vs. NF2

A

NF1: GTPase that negatively regulates RAS = Nerve sheat tumors peripherally with neurofibromas

NF2: Encodes merlin a cytoskeletal protein for contact inhibition. Loss of function leads to neurofibromatosis 2 = high risk of bilateral schwannomas.

18
Q

What tumor is WT1 linked to?

A

WT1: Needed for genitourinary development. Loss of function = Wilms Tumor in kids in kidneys

19
Q

What is PTCH1 linked to?

A

PTCH1: Encodes memrane receptor that is negative regulator of hedgehog pathway. Germline loss of function yields Gorlin syndrome = high risk of basal cell carcinoma and medulloblastoma.

20
Q

What is VHL and how does it link to cancer?

A

VHL: Encodes component of ubiquitin ligase responsible for hypoxia induced factors (factors that activate in low oxygen). Loss of function = VonHippel Lindau = Renal cell carcinoma and pheochromocytoma risk is way up.

21
Q

Discuss how apoptosis generally occurs and what cancer does to stop this.

A

Initiated through extrinsic or intrinsic pathways that results in proteolytic cascade of caspases that destroys the cells. Abnormalities of either can be found in cancer cells, but lesions that incapacitate the intrinsic mitochondria pathway are the most common.

22
Q

What is happening with Follicular B-Cell Lymphoma that is linked to apoptosis?

A

In follicular B-Cell lymphoma, the anti-apoptotic gene BCL-2 is overexpressed due to a 14:18 translocation.

Overexpression of other BCL-2 members like MCL-1 linked to cancer survival and drug resistance.

23
Q

How can cancer keep replicating permanently?

A

Cancer cells acquire lesions that inactivate senescence signals and reactivate telomerase, which act together to convey limitless replicative potential.

24
Q

How important is angiogenesis to cancer growth and what mutations tend to help this out?

A

Cancer cell masses can’t grow beyond 1-2mm in size without angiogenesis. Relative lack of oxygen stabilizes HIF-1a which then activates proangiogenic cytokines like VEGF

Loss of p53 causes angiogenesis because p53 normally makes factors like thrombospondin-1 which is antiangiogenic.

RAS-MAP kinase pathway also stimulates angiogenesis

25
Q

How do we fight the angiogenesis we see in cancers?

A

We use VEGF inhibitors for treatment in order to stop progression, although this is not curative.

26
Q

What four things need to occur for invasion and metastasis to occur in cancer?

A

Four steps to gaining the ability to invade and metastasize:

  • Loosening of cell-cell contacts (inactivation of E-cadherin)
  • degradation of ECM (proteolytic enzymes from the tumor such as metalloproteses and cathepsins)
  • attachment to new ECM components
  • migration of tumor cells.